iStock/WoodysPhotos(NEW YORK) — A group of executives for OxyContin maker Purdue Pharma have held a United States patent since 2007 for a “self-destructing document and e-mail messaging system.” This patent, filed in 2002, replaced a similar one from 1997 that was meant to destroy documents or email “at a predetermined time by attaching a ‘virus’ …
May 28
One year after OxyContin launched, Purdue Pharma execs applied to patent ‘self-destructing’ emails
